{"version":"1.0","type":"link","title":"FAPI-Based Theranostics in Medullary Thyroid Cancer: A Viable Alternative When Somatostatin Receptor-Based Theranostics Show Limited Efficacy-A Clinical Experience.","author_name":"Saber Tanha A 외","author_url":"https://prs-insight.online/author/Saber%20Tanha%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/138908","thumbnail_width":1200,"thumbnail_height":630}